Fri, Aug 29, 2014, 10:51 AM EDT - U.S. Markets close in 5 hrs 9 mins

Recent

% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • freetoquestionu freetoquestionu Oct 14, 2006 11:12 AM Flag

    What pipeline ?

    Billyteex1,

    I think it is important for the longs to discuss what opportunities SUPG has and what hurdles need to be cleared. The Manuso clause has received other discussions, from the boards I watch and the general feeling is that it is very unigue. I was drawn to SUPG because of all the careless negative comments that were posted. I also like the fact the longs are starting to discuss when to take profits...both these usually indicate that the stock will move higher. Long term the focus on pipeline should begin soon with the company laying out the foundation and expectations. I'm equally impressed by the conservative approach SUPG has taken. Instead of giving a large piece of the shareholders equity away to top brass, they actually eliminated a position and sold off non core assets. Look internally at this company and there are some nice signs that they want to grow this company. If SUPG partners with a large pharma on any of it's pipeline,then my suggestion is to hold long term. They will minimize burn and big pharma doesn't enter into these deals with out DD.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Upper management is hungry. The fact that they keep presenting themselves to the investment community shows sign that there is no complacency in SUPG. I also like their location being in Dublin Norcal where some big Pharmas are around. Genentech is only a hop across the Bay Bridge and Orathrecin(for solid Tumors) can be an eye opener for the like of DNA. I like it and will buy on any pull back.

 
ASTX
8.4950.000(0.00%)Oct 10 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.